iTeos Therapeutics, Inc. (ITOS) Tops Q1 EPS by 13c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q1 EPS of ($0.80), $0.13 better than the analyst estimate of ($0.93).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Eternity Founders Mohamad Al-Shami and Omar Abu Ghoush Announce US$1 Million Valuation
• RoundHill T-Rex 2X Long (RAM) call put ratio 2.7 calls to 1 put on active option volume of 23K contracts as share price up 9.8%